Future research should aim to increase the sample size to validate these results and further investigate the functional roles of TOP2A and HMGB2 in the pathogenesis and treatment resistance of hepatocellular carcinoma (HB). This evidence concerns the gene HMGB2 and hepatocellular carcinoma.